LENZ Therapeutics, Inc. LENZ
3.92
0.20
5.38%
as of 25 Sep
- Market cap
- $117.4M
- P/E
- 0.0×
Follow LENZ
Insider Buys
alert about insiders buying in the last 12 month
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | — | — | — | 0.00 |
P/S ratio |
— | — | — | — | — | — | — | 0.00 |
P/FCF ratio |
— | — | — | — | — | — | — | 0.00 |
P/Operating CF |
— | — | — | — | — | — | — | (13.96) |
P/B ratio |
— | — | — | — | — | — | — | 1.62 |
Price to Tangible BV |
— | — | — | — | — | — | — | 1.62 |
EV/Sales |
— | — | — | — | — | — | — | 0.00 |
EV/EBITDA |
— | — | — | — | — | — | — | 0.00 |
EV/Operating CF |
— | — | — | — | — | — | — | (2.49) |
EV/FCF |
— | — | — | — | — | — | — | (2.46) |
Quick Ratio |
— | 0.00 | 0.62 | 31.04 | 20.57 | 3.55 | 20.10 | 13.81 |
Current Ratio |
— | 0.00 | 0.66 | 31.44 | 21.11 | 3.63 | 20.36 | 14.23 |
Net Debt/EBITDA |
— | (75.83) | 1.48 | 6.31 | 2.52 | 0.90 | 3.57 | 3.22 |
Debt/Assets |
0.00% | 36,750.00% | 0.00% | 0.00% | 1.26% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | (0.99) | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 |
Operating CF/Net income |
— | 0.17 | 0.13 | 0.75 | 0.87 | 0.86 | 1.19 | 0.84 |
Capex/Depreciation |
— | — | (12.77) | (7.82) | (8.77) | 0.03 | (8.07) | (2.88) |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 0.32% | 202.21% | (44.41%) | (29.71%) | (68.74%) | (89.37%) | (33.63%) | |
| — | (3,633.33%) | (605.88%) | (33.33%) | (27.92%) | (35.67%) | (34.84%) | (31.52%) | |
ROIC |
— | 0.00% | 0.00% | (534.02%) | (205.64%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
— | 4.91% | 720.93% | (18.81%) | (35.46%) | (143.42%) | (24.62%) | (29.18%) |
Average Days of Receivables |
— | — | — | — | — | — | — | 6.29 |
Research and Development Expense of Revenue |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 97.81% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 477.46% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 65.73% |
Graham Net Nets |
— | — | — | — | — | — | — | 0.61 |
Graham Number |
— | — | — | — | — | — | — | 0.00 |
Earnings Yield |
— | — | — | — | — | — | — | (17.56%) |
Free Cash Flow Yield |
— | — | — | — | — | — | — | (15.18%) |
Revenue per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.66 |
Operating CF per Share |
— | 0.00 | (26.72) | (12.79) | (11.22) | (30.82) | (2.79) | (2.40) |
Capex per Share |
— | 0.00 | (4.73) | (1.39) | (0.84) | (0.02) | (0.02) | (0.03) |
Free Cash Flow per Share |
— | 0.00 | (31.45) | (14.18) | (12.06) | (30.84) | (2.81) | (2.43) |
Cash per Share |
— | 0.00 | 60.71 | 91.22 | 34.21 | 33.59 | 9.83 | 10.15 |
Shareholders Equity per Share |
— | 0.00 | (200.39) | 92.93 | 37.79 | (47.33) | 9.59 | 9.87 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.00 | (200.39) | 92.93 | 37.79 | (47.33) | 9.59 | 9.87 |
Free Cash Flow |
— | (0.02) | (10.27) | (58.59) | (94.57) | (60.41) | (59.86) | (70.00) |
Working Capital |
— | (2.22) | (10.94) | 369.59 | 262.32 | 48.73 | 201.51 | 280.23 |
Capital Expenditures |
— | — | (1.54) | (5.74) | (6.59) | (0.03) | (0.47) | (0.83) |
Net Current Asset Value |
— | (2.22) | (66.87) | 363.80 | 249.75 | (95.84) | 200.70 | 279.88 |
EV/EBIT |
— | — | — | — | — | — | — | 0.00 |
Capex to Sales |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 |
Net Profit Margin |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (430.25%) |
Price to Operating Income |
— | — | — | — | — | — | — | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | — | 0.08 | 0.11 | 0.03 | (19.30) | 0.09 | 0.24 |
Cash ROIC |
— | 271.43% | 22.33% | (7.80%) | (19.45%) | 224.51% | (14.53%) | (12.20%) |
Accounts Receivable Turnover |
— | — | — | — | — | — | — | 0.00 |
Accounts Payable Turnover |
— | — | 0.08 | 0.48 | 3.30 | 0.00 | 0.00 | 0.10 |
Inventory Turnover |
— | — | 0.00 | 0.00 | 0.00 | — | — | 0.00 |
Average Days of Payables |
— | — | 1,900.41 | 1,219.82 | 114.06 | 0.00 | 0.00 | 3,638.65 |
Days of Inventory on Hand |
— | — | 0.00 | 0.00 | 0.00 | — | — | 2,563.73 |
Average Payables |
— | — | 1.54 | 1.54 | 2.53 | 4.16 | 4.98 | 4.21 |
Average Assets |
— | 0.00 | 11.29 | 212.28 | 361.94 | 196.14 | 142.84 | 260.59 |
Average Common Equity |
— | (33.81) | (33.81) | 159.32 | 340.17 | 101.79 | 55.69 | 244.21 |
Columns are period end dates